Currently Open Funding Opportunity Announcements Relevant to Healthcare Delivery Research
This page includes currently open Funding Opportunity Announcements (FOAs) sponsored or co-sponsored by HDRP; other FOAs relevant to HDRP; and NIH and NCI Parent and Omnibus FOAs for investigator-initiated research. Descriptions of the most commonly used grant mechanisms can be found on the NIH Grants & Funding pages
and full FOA presentations are available on the FOA webinars page. If you have questions about a grant application, please contact the NCI Program Director listed on the FOA.
FOAs Sponsored or Co-Sponsored by HDRP
| Announcement Title | Announcement Number (Mechanism) |
Expiration Date | Program Contact |
|---|---|---|---|
| Multilevel Interventions in Cancer Care Delivery: Follow-up to Abnormal Screening Tests | PA-17-495 (R01 Clinical Trial Optional) |
January 8, 2021 | Erica Breslau 240-276-6773 breslaue@mail.nih.gov |
| Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer | PA-18-492 (R21 Clinical Trial Optional) PA-18-493 (R01 Clinical Trial Optional)
|
May 8, 2021 | Gurvaneet Randhawa 240-276-6940 gurvaneet.randhawa@nih.gov |
| Investigator-Initiated Research on Genetic Counseling Processes and Practices | RFA-HG-20-048 (R01 Clinical Trial Optional) |
July 8, 2021 | Erica Breslau 240-276-6773 breslaue@mail.nih.gov |
| Notice of Special Interest: NCI’s Interest in Research to Improve Interprofessional Teamwork and Coordination During Cancer Diagnosis and Treatment | NOT-CA-19-059 |
January 8, 2022 | Sallie Weaver 240-276-6254 sallie.weaver@nih.gov |
| Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations | PA-18-932 (R01 Clinical Trial Optional) |
January 8, 2022 | Erica Breslau 240-276-6773 breslaue@mail.nih.gov |
| End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses | PAR-19-136 (R01 Clinical Trial Optional) PAR-19-153 (R21 Clinical Trial Optional)
|
January 8, 2022 | Ashley Wilder Smith 240-276-7621 smithas@mail.nih.gov |
| Notice of Special Interest: De-implementation of Ineffective or Low-value Clinical Practices along the Cancer Care Continuum | NOT-CA-20-021 |
May 10, 2022 | Erica S. Breslau 240-276-6773 breslaue@mail.nih.gov |
| Surgical Disparities Research (R01) | PAR-20-079 |
July 6, 2022 | Brenda Adjei 240-276-6185 brenda.adjei@nih.gov |
| Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake | PAR-19-359 (R03 Clinical Trial Optional) |
July 17, 2022 | Veronica Chollette cholletv@mail.nih.gov |
| Notice of Special Interest: Health Services Research on Minority Health and Health Disparities | NOT-MD-20-011 (R01 Clinical Trial Optional) |
September 8, 2022 | Brenda Adjei 240-276-6185 adjeiba@mail.nih.gov |
| Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake | PAR-19-360 (R01 Clinical Trial Optional) |
September 8, 2022 | Veronica Chollette cholletv@mail.nih.gov |
| Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake | PAR-19-358 (R21 Clinical Trial Optional) |
September 8, 2022 | Veronica Chollette cholletv@mail.nih.gov |
| Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization | PAR-19-352 (R01 Clinical Trial Optional) |
September 8, 2022 | Michelle Mollica 240-276-7621 michelle.mollica@nih.gov |
| Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization | PAR-19-355 (R21 Clinical Trial Optional) |
September 8, 2022 | Michelle Mollica 240-276-7621 michelle.mollica@nih.gov |
| Notice of Special Interest: Tailoring Follow-up Care for Survivors Using Risk-Stratified Pathways | NOT-CA-21-019 |
February 5, 2023 | Michelle Mollica 240-276-7621 michelle.mollica@nih.gov |
| Notice of Special Interest: Research on Oral Anticancer Agents in the Contexts of Utilization, Adherence, and Health Care Delivery | NOT-CA-20-026 |
May 8, 2023 | Kate Castro 240-276-6834 kathleen.castro@nih.gov |
| Advancing Research to Develop Improved Measures and Methods for Understanding Multimorbidity (R01 Clinical Trial Optional) | PAR-20-179 |
September 8, 2023 | Bryan Kim bryan.kim@nih.gov |
| Identifying Innovative Mechanisms or Interventions that Target Multimorbidity and Its Consequences (R01 Clinical Trial Optional) | PAR-20-180 |
September 8, 2023 | Bryan Kim bryan.kim@nih.gov |
| Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional) | PA-20-172 |
September 8, 2023 | Sallie Weaver 240-276-6254 sallie.weaver@nih.gov |
Other FOAs Relevant to HDRP
| Announcement Title | Announcement Number (Mechanism) |
Expiration Date | Program Contact |
|---|---|---|---|
| Dissemination and Implementation Research in Health | PAR-19-274 (R01) PAR-19-275 (R21) PAR-19-276 (R03) |
May 8, 2022 | Gila Neta 240-276-6785 netagil@mail.nih.gov Wynne E. Norton, Ph.D. National Cancer Institute (NCI) 240-276-6875 Wynne.Norton@nih.gov David Chambers 240-276-5090 dchamber@mail.nih.gov |
NIH and NCI Parent and Omnibus FOAs for Investigator-Initiated Research
| Announcement Title | Announcement Number (Mechanism) |
Expiration Date |
|---|---|---|
| NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) | PA-18-484 (R01)
|
January 8, 2021 |
| Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional) | PAR-18-869
|
March 9, 2021 |
| Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required) | PAR-21-035
|
January 8, 2024 |
Visit https://grants.nih.gov/grants/guide/parent_announcements.htm for a full list of all NIH parent announcements.